Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease

被引:26
|
作者
Lee, Meng-Rui [1 ,2 ]
Yang, Ching-Yao [1 ]
Chang, Kai-Ping [1 ]
Keng, Li-Ta [1 ,3 ]
Yen, David Hung-Tsang [3 ,4 ]
Wang, Jann-Yuan [1 ]
Wu, Huey-Dong [1 ]
Lee, Li-Na [5 ]
Yu, Chong-Jen [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Taoyuan Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan
[3] Kinmen Hosp, Dept Internal Med, Kinmen, Taiwan
[4] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency Med, Taipei 112, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
FORCED EXPIRATORY VOLUME; QUALITY-OF-LIFE; PERFORMANCE ASSESSMENT; TUBERCULOSIS; BRONCHIECTASIS; INFECTIONS; SPIROMETRY; ADULTS; ABSCESSUS; SMOKING;
D O I
10.1371/journal.pone.0058214
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There is paucity of risk factors on lung function decline among patients with non-tuberculous mycobacteria (NTM) pulmonary disease in literature. Methods: Patients with NTM pulmonary disease between January 2000 and April 2011 were retrospectively selected. Sixty-eight patients had at least two pulmonary function tests within a mean follow-up period of 47 months. Results: Sixty-eight patients were included. They had a median age of 65 years and 65% had impaired lung function (Forced expiratory volume in 1 second [FEV1] <80% of predicted value). The mean FEV1 decline was 48 ml/year. By linear regression, younger age (beta: 0.472, p < 0.001), initial FEV1 >50% of predicted value (beta: 0.349, p = 0.002), male sex (beta: 0.295, p = 0.018), bronchiectasis pattern (beta: 0.232, p = 0.035), and radiographic score >3 (beta: 0.217, p = 0.049) were associated with greater FEV1 decline. Initial FEV1 >50% of predicted value (beta: 0.263, p = 0.032) was also associated with greater FVC annual decline, whereas M. kansasii pulmonary disease was marginally associated with greater annual FVC decline (beta: 0.227, p = 0.062). Conclusions: NTM pulmonary disease is associated with greater decline in lung function in patients who are young, male, with bronchiectasis, and with a high radiographic score. Special attention should be given to patients with these risk factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] EVALUATION OF CHEMOTHERAPY FOR PULMONARY NON-TUBERCULOUS MYCOBACTERIAL DISEASE
    Sato, Masamichi
    Abe, Shuichi
    Abe, Yuki
    Sato, Kento
    Nemoto, Takako
    Nunomiya, Keiko
    Kimura, Tomomi
    Yamauchi, Keiko
    Igarashi, Akira
    Inoue, Sumito
    Shibata, Yoko
    Kubota, Isao
    RESPIROLOGY, 2014, 19 : 212 - 212
  • [22] Burden of non-tuberculous mycobacterial pulmonary disease in Germany
    Diel, Roland
    Jacob, Josephine
    Lampenius, Niklas
    Loebinger, Michael
    Nienhaus, Albert
    Rabe, Klaus F.
    Ringshausen, Felix C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [23] When is a non-tuberculous mycobacterial infection a pulmonary disease?
    Griffith, D. E.
    Lange, C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (07) : 855 - 856
  • [24] Adverse reactions in the treatment of patients with non-tuberculous lung mycobacterial pulmonary disease and the possibility of their solution
    Vladimirova, Elena B.
    Shmelev, Evgene I.
    Zaytseva, Anna S.
    Kasimtseva, Svetlana A.
    Shchepikhin, Evgeniy I.
    Smirnova, Tatiana G.
    Makaryants, Natalia N.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (11) : 1049 - 1055
  • [25] The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
    Meyad Alkarni
    Marc Lipman
    David M. Lowe
    Annals of Clinical Microbiology and Antimicrobials, 22
  • [26] Physiotherapy for patients with non-tuberculous mycobacterial disease
    Polastri, Massimiliano
    Comellini, Vittoria
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2021, 28 (02):
  • [27] Erratum to: Treatment of Non-Tuberculous Mycobacterial Lung Disease
    Julie V. Philley
    Mary Ann DeGroote
    Jennifer R. Honda
    Michael M. Chan
    Shannon Kasperbauer
    Nicholas D. Walter
    Edward D. Chan
    Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 297 - 298
  • [28] FACTORS AFFECTING IN-HOSPITAL MORTALITY OF NON-TUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE
    Tanaka, Goh
    Jo, Taisuke
    Yasunaga, Hideo
    Nagase, Takahide
    RESPIROLOGY, 2019, 24 : 133 - 133
  • [29] CHANGE IN LUNG FUNCTION IN NEVER-SMOKERS WITH NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE
    Kobayashi, Takehiko
    Tsuyuguchi, Kazunari
    Arai, Toru
    Tsuji, Taisuke
    Maekura, Toshiya
    Kurahara, Yu
    Sugimoto, Chikatoshi
    Minomo, Shojiro
    Nakao, Keiko
    Tokura, Sayoko
    Sasaki, Yumiko
    Hayashi, Seiji
    Inoue, Yoshikazu
    Suzuki, Katsuhiro
    RESPIROLOGY, 2017, 22 : 40 - 40
  • [30] Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease
    Goh Tanaka
    Taisuke Jo
    Hiroyuki Tamiya
    Yukiyo Sakamoto
    Wakae Hasegawa
    Hiroki Matsui
    Kiyohide Fushimi
    Hideo Yasunaga
    Takahide Nagase
    BMC Infectious Diseases, 21